InvestorsObserver
×
News Home

Do Traders Think Neximmune Inc (NEXI) Can Keep Climbing Thursday?

Thursday, November 30, 2023 10:38 AM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Neximmune Inc (NEXI) Can Keep Climbing Thursday?

Neximmune Inc (NEXI) stock is up 6.77% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Neximmune Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on NEXI!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With NEXI Stock Today?

Neximmune Inc (NEXI) stock is up 18.51% while the S&P 500 is lower by -0.01% as of 10:25 AM on Thursday, Nov 30. NEXI has risen $0.32 from the previous closing price of $1.73 on volume of 18,356 shares. Over the past year the S&P 500 is up 14.97% while NEXI is lower by -80.88%. NEXI lost -$42.01 per share in the over the last 12 months.

More About Neximmune Inc

NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology. It creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. Click Here to get the full Stock Report for Neximmune Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App